New Delhi: Hetero Labs has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard ...

Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on Phathom Pharmaceuticals (PHAT – Research Report) on November 8 and set ...

Net revenues of $16.4 million reported for the third quarter 2024 compared to $7.3 million in the second quarter 2024, over 120% sequential ...

The US regulator has cleared two therapies based on Phathom's acid blocker vonoprazan in combination with antibiotics for Helicobacter pylori infections , which are associated with peptic ulcer ...

Our Bureau, New Delhi Wednesday, November 6, 2024, 13:45 Hrs [IST] Dr Reddy's Laboratories has reported a decline of 9.36 pe ...

Hyderabad-based Dr Reddy's Laboratories (DRL) posted a 9.5 per cent year-on-year (Y-o-Y) decline in its consolidated profit ...

PHILADELPHIA — A new 10-day treatment regimen with the oral potassium-competitive acid blocker vonoprazan, and the antibiotics levofloxacin and amoxicillin, was significantly more effective at ...

Credit: Getty Images Researchers examined the frequency of heartburn among patients receiving treatment with on-demand vonoprazan. Patients with nonerosive reflux disease receiving treatment with ...

The PCAB available in the United States is Voquezna (vonoprazan). It works by blocking the acids secreted by the stomach.